Node-positive mucosal gastric cancer: a follow-up study
Lymph node metastasis from mucosal gastric carcinoma is rare and the prognosis of the patients has seldom been reported. Forty-five patients with node-positive mucosal gastric cancer were studied. They accounted for 2.5% of 1770 patients with mucosal gastric cancer who underwent gastrectomy with lym...
Gespeichert in:
| Veröffentlicht in: | Japanese journal of clinical oncology 2001-04, Vol.31 (4), p.153-156 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 156 |
|---|---|
| container_issue | 4 |
| container_start_page | 153 |
| container_title | Japanese journal of clinical oncology |
| container_volume | 31 |
| creator | Yamaguchi, T Sano, T Katai, H Sasako, M Maruyama, K |
| description | Lymph node metastasis from mucosal gastric carcinoma is rare and the prognosis of the patients has seldom been reported.
Forty-five patients with node-positive mucosal gastric cancer were studied. They accounted for 2.5% of 1770 patients with mucosal gastric cancer who underwent gastrectomy with lymphadenectomy at the National Cancer Center Hospital, Tokyo. The clinicopathological features were studied and the current clinical status was sought.
The majority of patients (87%) were treated with D2 lymphadenectomy. The metastasis was confined to the perigastric nodes (pN1 by Japanese classification) in 30 patients (67%). The number of positive nodes was less than seven (pN1 by TNM) in 42 patients (93%). Two patients had para-aortic nodal metastasis. The median follow-up period was 11 years. Four patients died of definite or possible recurrent disease and the disease-specific 5- and 10-year survival rates were 95 and 89%, respectively.
Although nodal metastasis is an important prognostic factor for gastric cancer, the prognosis was excellent as long as the primary tumor was confined to the mucosa and was treated with gastrectomy and lymphadenectomy. |
| doi_str_mv | 10.1093/jjco/hye035 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70894888</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>373954301</sourcerecordid><originalsourceid>FETCH-LOGICAL-c373t-6c0d1be7619ebd4bc8e3bfd077788a4025505dd1e02b60c1594369a306bebccf3</originalsourceid><addsrcrecordid>eNpd0EtLw0AUhuFBFFurK_cSXLiR2HMyyczEnRRvUHSj62Fu0YSkU2cSpf_elBYEV2fz8HF4CTlHuEEo6bxpjJ9_bhzQ4oBMMWdFSlmGh2QKlIk0E4gTchJjAwCFyPkxmSBSwXKGU8JfvHXp2se6r79d0g3GR9UmHyr2oTaJUSvjwm2iksq3rf9Jh3US-8FuTslRpdrozvZ3Rt4f7t8WT-ny9fF5cbdMDeW0T5kBi9pxhqXTNtdGOKorC5xzIVQOWVFAYS06yDQDg0WZU1YqCkw7bUxFZ-Rqt7sO_mtwsZddHY1rW7VyfoiSgyhzIcQIL__Bxg9hNf4mM-RjqAL5iK53yAQfY3CVXIe6U2EjEeQ2ptzGlLuYo77YTw66c_bP7uvRX50bcAU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>217109517</pqid></control><display><type>article</type><title>Node-positive mucosal gastric cancer: a follow-up study</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Freely Accessible Japanese Titles</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Yamaguchi, T ; Sano, T ; Katai, H ; Sasako, M ; Maruyama, K</creator><creatorcontrib>Yamaguchi, T ; Sano, T ; Katai, H ; Sasako, M ; Maruyama, K</creatorcontrib><description>Lymph node metastasis from mucosal gastric carcinoma is rare and the prognosis of the patients has seldom been reported.
Forty-five patients with node-positive mucosal gastric cancer were studied. They accounted for 2.5% of 1770 patients with mucosal gastric cancer who underwent gastrectomy with lymphadenectomy at the National Cancer Center Hospital, Tokyo. The clinicopathological features were studied and the current clinical status was sought.
The majority of patients (87%) were treated with D2 lymphadenectomy. The metastasis was confined to the perigastric nodes (pN1 by Japanese classification) in 30 patients (67%). The number of positive nodes was less than seven (pN1 by TNM) in 42 patients (93%). Two patients had para-aortic nodal metastasis. The median follow-up period was 11 years. Four patients died of definite or possible recurrent disease and the disease-specific 5- and 10-year survival rates were 95 and 89%, respectively.
Although nodal metastasis is an important prognostic factor for gastric cancer, the prognosis was excellent as long as the primary tumor was confined to the mucosa and was treated with gastrectomy and lymphadenectomy.</description><identifier>ISSN: 0368-2811</identifier><identifier>ISSN: 1465-3621</identifier><identifier>EISSN: 1465-3621</identifier><identifier>DOI: 10.1093/jjco/hye035</identifier><identifier>PMID: 11386461</identifier><language>eng</language><publisher>England: Oxford Publishing Limited (England)</publisher><subject>Adenocarcinoma - drug therapy ; Adenocarcinoma - secondary ; Adenocarcinoma - surgery ; Adult ; Aged ; Carcinoma, Signet Ring Cell - drug therapy ; Carcinoma, Signet Ring Cell - secondary ; Carcinoma, Signet Ring Cell - surgery ; Chemotherapy, Adjuvant ; Female ; Fluorouracil - administration & dosage ; Follow-Up Studies ; Gastric Mucosa - pathology ; Humans ; Lymph Nodes - pathology ; Lymphatic Metastasis ; Male ; Middle Aged ; Prognosis ; Stomach Neoplasms - drug therapy ; Stomach Neoplasms - pathology ; Stomach Neoplasms - surgery</subject><ispartof>Japanese journal of clinical oncology, 2001-04, Vol.31 (4), p.153-156</ispartof><rights>Copyright Oxford University Press(England) Apr 1, 2001</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c373t-6c0d1be7619ebd4bc8e3bfd077788a4025505dd1e02b60c1594369a306bebccf3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11386461$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yamaguchi, T</creatorcontrib><creatorcontrib>Sano, T</creatorcontrib><creatorcontrib>Katai, H</creatorcontrib><creatorcontrib>Sasako, M</creatorcontrib><creatorcontrib>Maruyama, K</creatorcontrib><title>Node-positive mucosal gastric cancer: a follow-up study</title><title>Japanese journal of clinical oncology</title><addtitle>Jpn J Clin Oncol</addtitle><description>Lymph node metastasis from mucosal gastric carcinoma is rare and the prognosis of the patients has seldom been reported.
Forty-five patients with node-positive mucosal gastric cancer were studied. They accounted for 2.5% of 1770 patients with mucosal gastric cancer who underwent gastrectomy with lymphadenectomy at the National Cancer Center Hospital, Tokyo. The clinicopathological features were studied and the current clinical status was sought.
The majority of patients (87%) were treated with D2 lymphadenectomy. The metastasis was confined to the perigastric nodes (pN1 by Japanese classification) in 30 patients (67%). The number of positive nodes was less than seven (pN1 by TNM) in 42 patients (93%). Two patients had para-aortic nodal metastasis. The median follow-up period was 11 years. Four patients died of definite or possible recurrent disease and the disease-specific 5- and 10-year survival rates were 95 and 89%, respectively.
Although nodal metastasis is an important prognostic factor for gastric cancer, the prognosis was excellent as long as the primary tumor was confined to the mucosa and was treated with gastrectomy and lymphadenectomy.</description><subject>Adenocarcinoma - drug therapy</subject><subject>Adenocarcinoma - secondary</subject><subject>Adenocarcinoma - surgery</subject><subject>Adult</subject><subject>Aged</subject><subject>Carcinoma, Signet Ring Cell - drug therapy</subject><subject>Carcinoma, Signet Ring Cell - secondary</subject><subject>Carcinoma, Signet Ring Cell - surgery</subject><subject>Chemotherapy, Adjuvant</subject><subject>Female</subject><subject>Fluorouracil - administration & dosage</subject><subject>Follow-Up Studies</subject><subject>Gastric Mucosa - pathology</subject><subject>Humans</subject><subject>Lymph Nodes - pathology</subject><subject>Lymphatic Metastasis</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Prognosis</subject><subject>Stomach Neoplasms - drug therapy</subject><subject>Stomach Neoplasms - pathology</subject><subject>Stomach Neoplasms - surgery</subject><issn>0368-2811</issn><issn>1465-3621</issn><issn>1465-3621</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpd0EtLw0AUhuFBFFurK_cSXLiR2HMyyczEnRRvUHSj62Fu0YSkU2cSpf_elBYEV2fz8HF4CTlHuEEo6bxpjJ9_bhzQ4oBMMWdFSlmGh2QKlIk0E4gTchJjAwCFyPkxmSBSwXKGU8JfvHXp2se6r79d0g3GR9UmHyr2oTaJUSvjwm2iksq3rf9Jh3US-8FuTslRpdrozvZ3Rt4f7t8WT-ny9fF5cbdMDeW0T5kBi9pxhqXTNtdGOKorC5xzIVQOWVFAYS06yDQDg0WZU1YqCkw7bUxFZ-Rqt7sO_mtwsZddHY1rW7VyfoiSgyhzIcQIL__Bxg9hNf4mM-RjqAL5iK53yAQfY3CVXIe6U2EjEeQ2ptzGlLuYo77YTw66c_bP7uvRX50bcAU</recordid><startdate>20010401</startdate><enddate>20010401</enddate><creator>Yamaguchi, T</creator><creator>Sano, T</creator><creator>Katai, H</creator><creator>Sasako, M</creator><creator>Maruyama, K</creator><general>Oxford Publishing Limited (England)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7T7</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20010401</creationdate><title>Node-positive mucosal gastric cancer: a follow-up study</title><author>Yamaguchi, T ; Sano, T ; Katai, H ; Sasako, M ; Maruyama, K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c373t-6c0d1be7619ebd4bc8e3bfd077788a4025505dd1e02b60c1594369a306bebccf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Adenocarcinoma - drug therapy</topic><topic>Adenocarcinoma - secondary</topic><topic>Adenocarcinoma - surgery</topic><topic>Adult</topic><topic>Aged</topic><topic>Carcinoma, Signet Ring Cell - drug therapy</topic><topic>Carcinoma, Signet Ring Cell - secondary</topic><topic>Carcinoma, Signet Ring Cell - surgery</topic><topic>Chemotherapy, Adjuvant</topic><topic>Female</topic><topic>Fluorouracil - administration & dosage</topic><topic>Follow-Up Studies</topic><topic>Gastric Mucosa - pathology</topic><topic>Humans</topic><topic>Lymph Nodes - pathology</topic><topic>Lymphatic Metastasis</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Prognosis</topic><topic>Stomach Neoplasms - drug therapy</topic><topic>Stomach Neoplasms - pathology</topic><topic>Stomach Neoplasms - surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yamaguchi, T</creatorcontrib><creatorcontrib>Sano, T</creatorcontrib><creatorcontrib>Katai, H</creatorcontrib><creatorcontrib>Sasako, M</creatorcontrib><creatorcontrib>Maruyama, K</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Japanese journal of clinical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yamaguchi, T</au><au>Sano, T</au><au>Katai, H</au><au>Sasako, M</au><au>Maruyama, K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Node-positive mucosal gastric cancer: a follow-up study</atitle><jtitle>Japanese journal of clinical oncology</jtitle><addtitle>Jpn J Clin Oncol</addtitle><date>2001-04-01</date><risdate>2001</risdate><volume>31</volume><issue>4</issue><spage>153</spage><epage>156</epage><pages>153-156</pages><issn>0368-2811</issn><issn>1465-3621</issn><eissn>1465-3621</eissn><abstract>Lymph node metastasis from mucosal gastric carcinoma is rare and the prognosis of the patients has seldom been reported.
Forty-five patients with node-positive mucosal gastric cancer were studied. They accounted for 2.5% of 1770 patients with mucosal gastric cancer who underwent gastrectomy with lymphadenectomy at the National Cancer Center Hospital, Tokyo. The clinicopathological features were studied and the current clinical status was sought.
The majority of patients (87%) were treated with D2 lymphadenectomy. The metastasis was confined to the perigastric nodes (pN1 by Japanese classification) in 30 patients (67%). The number of positive nodes was less than seven (pN1 by TNM) in 42 patients (93%). Two patients had para-aortic nodal metastasis. The median follow-up period was 11 years. Four patients died of definite or possible recurrent disease and the disease-specific 5- and 10-year survival rates were 95 and 89%, respectively.
Although nodal metastasis is an important prognostic factor for gastric cancer, the prognosis was excellent as long as the primary tumor was confined to the mucosa and was treated with gastrectomy and lymphadenectomy.</abstract><cop>England</cop><pub>Oxford Publishing Limited (England)</pub><pmid>11386461</pmid><doi>10.1093/jjco/hye035</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0368-2811 |
| ispartof | Japanese journal of clinical oncology, 2001-04, Vol.31 (4), p.153-156 |
| issn | 0368-2811 1465-3621 1465-3621 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_70894888 |
| source | MEDLINE; Oxford University Press Journals All Titles (1996-Current); Freely Accessible Japanese Titles; EZB-FREE-00999 freely available EZB journals |
| subjects | Adenocarcinoma - drug therapy Adenocarcinoma - secondary Adenocarcinoma - surgery Adult Aged Carcinoma, Signet Ring Cell - drug therapy Carcinoma, Signet Ring Cell - secondary Carcinoma, Signet Ring Cell - surgery Chemotherapy, Adjuvant Female Fluorouracil - administration & dosage Follow-Up Studies Gastric Mucosa - pathology Humans Lymph Nodes - pathology Lymphatic Metastasis Male Middle Aged Prognosis Stomach Neoplasms - drug therapy Stomach Neoplasms - pathology Stomach Neoplasms - surgery |
| title | Node-positive mucosal gastric cancer: a follow-up study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T08%3A37%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Node-positive%20mucosal%20gastric%20cancer:%20a%20follow-up%20study&rft.jtitle=Japanese%20journal%20of%20clinical%20oncology&rft.au=Yamaguchi,%20T&rft.date=2001-04-01&rft.volume=31&rft.issue=4&rft.spage=153&rft.epage=156&rft.pages=153-156&rft.issn=0368-2811&rft.eissn=1465-3621&rft_id=info:doi/10.1093/jjco/hye035&rft_dat=%3Cproquest_cross%3E373954301%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=217109517&rft_id=info:pmid/11386461&rfr_iscdi=true |